Bethesda, Md—Combination vaccines containing several antigenic components, making a single dose do double or triple duty, are essential if physicians are to take full advantage of new vaccines being developed to treat childhood diseases, but the road to their full clinical use needs some new markers. This was the essential conclusion from a meeting at the National Institutes of Health (NIH) on issues facing the development and licensure of new combination vaccines.
Marwick C. Clearing the Way for New Combination Vaccine Use. JAMA. 2000;283(10):1280-1281. doi:10.1001/jama.283.10.1280-JMN0308-5-1